Digoxin Immune Fab

Purity≥95% SDS-PAGE.Endotoxin level&lt:0.

Purity≥95% SDS-PAGE.Endotoxin level&lt:0.

Reparixin(DF 1681Y) is an inhibitor of CXCL8 receptor, also inhibit CXCR1 and CXCR2 activation, which has been shown to attenuate inflammatory responses in various injury models.

A potent anti-inflammatory mediator derived physiologically from the sequential oxygenation of DHA by 15- and 5-LO reduces human leukocyte transendothelial migration (EC50 = ~30 nM) and limits leukocyte infiltration in a mouse model of peritonitis.

IgG fraction Monoclonal Mouse Anti-Digoxin may be used either as direct conjugates, or for more sensitivity, they can be used unconjugated followed by a conjugated anti-mouse IgG (H+L) for signal enhancement. Target: Digoxin Host: Mouse Antibody

Biochem/physiol Actions RIPA-56 is a metabolically stable type III kinase inhibitor that targets receptor-interacting protein 1 kinase (RIP1: RIPK1) in a highly potent and selective manner (RIP1 IC50 = 13 nM) by locking RIP1 in its inactive form,

Biochem/physiol Actions RIPA-56 is a metabolically stable type III kinase inhibitor that targets receptor-interacting protein 1 kinase (RIP1: RIPK1) in a highly potent and selective manner (RIP1 IC50 = 13 nM) by locking RIP1 in its inactive form,

A mycotoxin first isolated from P. roqueforti that displays neurotoxic properties activates a P-glycoprotein transport system involved in the efflux of xenobiotics and inhibits cytochrome P450 3A detoxification enzymes.

A mycotoxin first isolated from P. roqueforti that displays neurotoxic properties activates a P-glycoprotein transport system involved in the efflux of xenobiotics and inhibits cytochrome P450 3A detoxification enzymes.

An inhibitor of HMG-CoA reductase (IC50 = 5 nM) that has been shown to be more effective than atorvastatin, simvastatin, or pravastatin in decreasing LDL cholesterol and increasing HDL cholesterol.

Application Spautin-1 has been used as an autophagy inhibitor: to study its effects on vascular, glial, and neuronal alterations in the oxygen-induced retinopathy mouse model to evaluate its pre-treatment effect on the response of canine

Application Spautin-1 has been used as an autophagy inhibitor: to study its effects on vascular, glial, and neuronal alterations in the oxygen-induced retinopathy mouse model to evaluate its pre-treatment effect on the response of canine